The Latest in IT Security

Sony forms genome analysis company in move towards personalized medicine

23
Jan
2014

Sony is forming a new company to focus on genome research with a view towards realizing personalized medicine and healthcare. The venture, currently called P5 Inc, is a collaboration with M3, a medical company in which Sony is the majority stakeholder, and Illumina, a US-based manufacturer of genome-sequencing equipment. News of the tie-up between Sony and Illumina, which will be a minority investor, was first reported by Jiji Press last year. The medical sector is increasingly important to Sony

Comments are closed.

Categories

THURSDAY, SEPTEMBER 19, 2019
WHITE PAPERS

Mission-Critical Broadband – Why Governments Should Partner with Commercial Operators:
Many governments embrace mobile network operator (MNO) networks as ...

ARA at Scale: How to Choose a Solution That Grows With Your Needs:
Application release automation (ARA) tools enable best practices in...

The Multi-Model Database:
Part of the “new normal” where data and cloud applications are ...

Featured

Archives

Latest Comments

Social Networks